Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies.
Saved in:
| Title: | Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies. |
|---|---|
| Authors: | Wang J; Department of Thyroid Surgery, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China., Cao G; Department of Thyroid Surgery, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China., Liu Y; Department of Thyroid Surgery, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China., Qiao H; Department of Thyroid Surgery, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China., He Q; Department of Thyroid Surgery, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China., Zheng B; Department of General Surgery, Xi'an Gaoxin Hospital, Xi'an, China. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Jun 22; Vol. 17, pp. 1851074. Date of Electronic Publication: 2026 Jun 22 (Print Publication: 2026). |
| Publication Type: | Journal Article; Network Meta-Analysis; Comparative Study; Systematic Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2026.1851074 |
